FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Susan Hamilton

Research Profile

Procedures

Double-Blind Method

Chemicals & Drugs

Disorders

Concepts & Ideas

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Charles Beasley; Virginia K Sutton; Susan H Hamilton; Daniel J Walker; Martin Dossenbach; Cindy C Taylor; Karla Alaka; Deborah Bykowski; Gary D Tollefson
A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse.
Susan H Hamilton; Eric T Edgell; Dennis A Revicki; Alan Breier
Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample.
Dennis A Revicki; LA Genduso; Susan H Hamilton; D Ganoczy; Charles Beasley
Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Susan Hamilton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Charles Beasley; Virginia K Sutton; Susan H Hamilton; Daniel J Walker; Martin Dossenbach; Cindy C Taylor; Karla Alaka; Deborah Bykowski; Gary D Tollefson
A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse.
Journal of clinical psychopharmacology 2003;23(6):582-94.
2000: Susan H Hamilton; Eric T Edgell; Dennis A Revicki; Alan Breier
Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample.
International clinical psychopharmacology 2000;15(5):245-55.
1999: Dennis A Revicki; LA Genduso; Susan H Hamilton; D Ganoczy; Charles Beasley
Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1999;8(5):417-26.
1999: Susan H Hamilton; Dennis A Revicki; Eric T Edgell; LA Genduso; Gary D Tollefson
Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial.
PharmacoEconomics 1999;15(5):469-80.
1999: Alan Breier; Susan H Hamilton
Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia.
Biological psychiatry 1999;45(4):403-11.
1998: Cynthia S Palmer; Dennis A Revicki; LA Genduso; Susan H Hamilton; R E Brown
A cost-effectiveness clinical decision analysis model for schizophrenia.
The American journal of managed care 1998;4(3):345-55.
1998: Susan H Hamilton; Dennis A Revicki; LA Genduso; Charles Beasley
Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;18(1):41-9.
1997: Pierre V Tran; Susan H Hamilton; A J Kuntz; JH Potvin; Scott W Andersen; C Beasley; Gary D Tollefson
Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.
Journal of clinical psychopharmacology 1997;17(5):407-18.
1997: David J Goldstein; Susan H Hamilton; D N Masica; Charles Beasley
Fluoxetine in medically stable, depressed geriatric patients: effects on weight.
Journal of clinical psychopharmacology 1997;17(5):365-9.
1997: Charles Beasley; Susan H Hamilton; AM Crawford; MA Dellva; Gary D Tollefson; Pierre V Tran; O Blin; J N Beuzen
Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1997;7(2):125-37.
1995: L M Koran; Susan H Hamilton; M Hertzman; B S Meyers; A E Halaris; Gary D Tollefson; J M Downs; D G Folks; D V Jeste; L W Lazarus
Predicting response to fluoxetine in geriatric patients with major depression.
Journal of clinical psychopharmacology 1995;15(6):421-7.
1995: David J Goldstein; A H Rampey; P J Roback; M G Wilson; Susan H Hamilton; M E Sayler; G D Tollefson
Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success.
Obesity research 1995;3 Suppl 4():481S-490S.
1995: Gary W Small; Susan H Hamilton; Alexander Bystritsky; B S Meyers; Charles Nemeroff
Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study Group.
International psychogeriatrics / IPA 1995;7 Suppl():41-53.